Analysed CELCUITY INC (CELC:NASDAQ) News Sources
Celcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
02-06-2026
biopharmadive.com
Celcuity Says Gedatolisib Outperforms Novartis' Alpelisib Plus Fulvestrant in Phase 3 Trial
02-06-2026
yahoo.com
CELC Stock Records Worst Day Ever After Late-Stage Breast Cancer Trial Results — What’s Driving The Selloff?
02-06-2026
stocktwits.com
US Equity Futures Mixed Pre-Bell as US, Iran Continue Military Strikes in Middle East
03-06-2026
yahoo.com
Celcuity Inc. Announces Pricing of Upsized Public Offering of 0.250% Convertible Senior Notes Due 2032
04-06-2026
yahoo.com
Celcuity (CELC) Expands Phase 3 VIKTORIA-2 Trial to Include Endocrine-Sensitive Breast Cancer Patients
04-06-2026
yahoo.com
What is the current price of CELCUITY INC (CELC:NASDAQ)?
The current price of CELCUITY INC (CELC:NASDAQ) is $88.55.
CELCUITY INC (CELC:NASDAQ) absolute price change since previous trading day?
The absolute price change of CELCUITY INC (CELC:NASDAQ) since the previous trading day is $-0.94.
CELCUITY INC (CELC:NASDAQ) percentage price change since previous trading day?
The percentage price change of CELCUITY INC (CELC:NASDAQ) since the previous trading day is -1.0504%.
What is the most recent average sentiment score for CELCUITY INC (CELC:NASDAQ)?
The most recent average sentiment score for CELCUITY INC (CELC:NASDAQ) is 58 out of 100.
What is the most recent average sentiment for CELCUITY INC (CELC:NASDAQ)?
The most recent sentiment for CELCUITY INC (CELC:NASDAQ) is .
SEC-8K** Filing Available For CELCUITY INC (CELC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.